SWM
SeaCrest Wealth Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,364
| Closed | -$229K | – | 620 |
|
|
2024
Q1 | $229K | Buy |
+3,364
| New | +$229K | 0.03% | 533 |
|
|
2022
Q3 | – | Sell |
-1,224
| Closed | -$74K | – | 808 |
|
|
2022
Q2 | $74K | Buy |
+1,224
| New | +$74K | 0.01% | 963 |
|
|
2021
Q4 | – | Sell |
-9,218
| Closed | -$1.03M | – | 711 |
|
|
2021
Q3 | $1.03M | Buy |
9,218
+7,764
| +534% | +$869K | 0.12% | 178 |
|
|
2021
Q2 | $235K | Sell |
1,454
-255
| -15% | -$41.2K | 0.03% | 583 |
|
|
2021
Q1 | $208K | Sell |
1,709
-2,013
| -54% | -$245K | 0.03% | 599 |
|
|
2020
Q4 | $570K | Buy |
3,722
+353
| +10% | +$54.1K | 0.08% | 260 |
|
|
2020
Q3 | $282K | Sell |
3,369
-5,544
| -62% | -$464K | 0.05% | 414 |
|
|
2020
Q2 | $655K | Buy |
+8,913
| New | +$655K | 0.11% | 208 |
|
|
2019
Q2 | – | Sell |
-757
| Closed | -$27K | – | 785 |
|
|
2019
Q1 | $27K | Buy |
757
+69
| +10% | +$2.46K | ﹤0.01% | 1153 |
|
|
2018
Q4 | $20K | Sell |
688
-240
| -26% | -$6.98K | ﹤0.01% | 1230 |
|
|
2018
Q3 | $41K | Sell |
928
-1,798
| -66% | -$79.4K | 0.01% | 1079 |
|
|
2018
Q2 | $160K | Buy |
2,726
+1,826
| +203% | +$107K | 0.03% | 569 |
|
|
2018
Q1 | $41K | Buy |
+900
| New | +$41K | 0.01% | 1035 |
|